genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2011
Kidney cancer
Insights
2011 IPO Window for Biotechs Lets Through Fewer Companies
Cancer
Agenus, NewVac Ink Cancer Vaccine Deal in Russia
Cancer
ArGEN-X Licenses BioWa’s Potelligent Platform to Generate More Potent Antibodies
Cancer
Scientists Suggest a Molecular Pathway that May Identify RCC Patients Likely to Respond to Dasatinib
Cancer
Phase III Trial Finds Pfizer’s Axitinib Better than Sorafenib at Boosting PFS in Renal Cell Cancer
Insights
SBS Conference Features Diverse New Product Range
Cancer
FDA Clears Novartis’ Afinitor for Treating Advanced Pancreatic NET
Cancer
Prometheus Pays Wilex $19M for U.S. Rights to Phase III Anticancer mAb
Cancer
Kite Pharma Raises $15M in Initial Private Placement to Progress Anticancer Pipeline
Cancer
Astellas Gains Ex-Asia Rights to Aveo’s Phase III Cancer Drug
1
...
5
6
7
...
9
Page 6 of 9
Scroll Up